Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McGing

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Irish Medical Journal|July 1, 2017
Potential impact of cycle of care on Diabetes services in secondary careJ Finnegan, P McGing, M Hatunic
Irish Journal of Medical Science|March 1, 1989
The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancerM Teeling, P McGing, D N Carney
Journal of Internal Medicine|October 1, 1989
Ketosis, a complication of theophylline toxicityT Ryan, G Coughlan, P McGing, et al.
Seminars in Oncology|February 1, 1992
Carboplatin/cyclophosphamide combination chemotherapy for advanced ovarian cancerM Teeling, Y Hayes, B Fitzmaurice, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
The role of methionine in the intracellular accumulation and function of folatesJ M Scott, B McKenna, P McGing, et al.
Irish Journal of Medical Science|July 1, 1996
Cholesterol levels in normal Irish adults: the Mater Hospital Cholesterol Screening SurveyJ F Collier, S Maguire, P McGing, et al.
Anticancer Research|September 2, 1999
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patientsA van Dalen, J Favier, L Baumgartner, et al.
Anticancer Research|May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancerA Van Dalen, J Favier, L Baumgartner, et al.
Gynecologic Oncology|December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patientsA van Dalen, J Favier, A Burges, et al.
European Journal of Gynaecological Oncology|January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-upA van Dalen, J Favier, E Hallensleben, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Irish Medical Journal|July 1, 2017
Potential impact of cycle of care on Diabetes services in secondary careJ Finnegan, P McGing, M Hatunic
Irish Journal of Medical Science|March 1, 1989
The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancerM Teeling, P McGing, D N Carney
Journal of Internal Medicine|October 1, 1989
Ketosis, a complication of theophylline toxicityT Ryan, G Coughlan, P McGing, et al.
Seminars in Oncology|February 1, 1992
Carboplatin/cyclophosphamide combination chemotherapy for advanced ovarian cancerM Teeling, Y Hayes, B Fitzmaurice, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
The role of methionine in the intracellular accumulation and function of folatesJ M Scott, B McKenna, P McGing, et al.
Irish Journal of Medical Science|July 1, 1996
Cholesterol levels in normal Irish adults: the Mater Hospital Cholesterol Screening SurveyJ F Collier, S Maguire, P McGing, et al.
Anticancer Research|September 2, 1999
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patientsA van Dalen, J Favier, L Baumgartner, et al.
Anticancer Research|May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancerA Van Dalen, J Favier, L Baumgartner, et al.
Gynecologic Oncology|December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patientsA van Dalen, J Favier, A Burges, et al.
European Journal of Gynaecological Oncology|January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-upA van Dalen, J Favier, E Hallensleben, et al.
Pageof 1